First device tracks blood sugar and ketones continuously

The U.S. Food and Drug Administration has announced its approval for the marketing of the first-ever wearable device that continuously monitors blood sugar and ketone levels. The device is called "Libre Duo 10 Day." It is used by diabetic patients aged two years and older and measures ketone and glucose levels every minute over a period of 10 days. The readings are wirelessly transmitted to a smartphone, with automatic alerts if ketone levels rise to a concerning level. The device helps detect early signs of diabetic ketoacidosis before it becomes a life-threatening emergency, allowing continuous trend tracking instead of traditional spot tests. This facilitates early intervention and helps prevent potential complications.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل